Kestra Advisory Services’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $34.2M | Buy |
1,409,516
+268,402
| +24% | +$6.51M | 0.17% | 110 |
|
|
2025
Q1 | $28.9M | Sell |
1,141,114
-21,143
| -2% | -$536K | 0.14% | 116 |
|
|
2024
Q4 | $30.8M | Sell |
1,162,257
-152,429
| -12% | -$4.04M | 0.17% | 114 |
|
|
2024
Q3 | $38M | Sell |
1,314,686
-44,722
| -3% | -$1.29M | 0.21% | 92 |
|
|
2024
Q2 | $35.9M | Buy |
1,359,408
+372,152
| +38% | +$9.82M | 0.2% | 91 |
|
|
2024
Q1 | $27.4M | Buy |
987,256
+288,602
| +41% | +$8.01M | 0.18% | 110 |
|
|
2023
Q4 | $20.1M | Sell |
698,654
-37,880
| -5% | -$1.09M | 0.16% | 117 |
|
|
2023
Q3 | $24.4M | Buy |
736,534
+22,036
| +3% | +$731K | 0.24% | 85 |
|
|
2023
Q2 | $26.2M | Buy |
714,498
+153,170
| +27% | +$5.62M | 0.26% | 77 |
|
|
2023
Q1 | $22.9M | Sell |
561,328
-165,093
| -23% | -$6.74M | 0.25% | 83 |
|
|
2022
Q4 | $37.2M | Sell |
726,421
-11,601
| -2% | -$594K | 0.33% | 54 |
|
|
2022
Q3 | $32.3M | Buy |
738,022
+86,449
| +13% | +$3.78M | 0.35% | 56 |
|
|
2022
Q2 | $34.2M | Buy |
651,573
+95,704
| +17% | +$5.02M | 0.35% | 51 |
|
|
2022
Q1 | $28.8M | Sell |
555,869
-81,224
| -13% | -$4.2M | 0.3% | 64 |
|
|
2021
Q4 | $37.6M | Sell |
637,093
-144,208
| -18% | -$8.52M | 0.38% | 51 |
|
|
2021
Q3 | $33.6M | Buy |
781,301
+151,936
| +24% | +$6.53M | 0.34% | 58 |
|
|
2021
Q2 | $24.6M | Sell |
629,365
-530
| -0.1% | -$20.8K | 0.28% | 75 |
|
|
2021
Q1 | $22.8M | Sell |
629,895
-218,714
| -26% | -$7.92M | 0.29% | 75 |
|
|
2020
Q4 | $31.2M | Buy |
848,609
+324,164
| +62% | +$11.9M | 0.36% | 55 |
|
|
2020
Q3 | $18.3M | Buy |
+524,445
| New | +$18.3M | 0.34% | 61 |
|